esmo 2014摘要1156第39届大会西牙马德里年9月26日至.pdfVIP

th 39 ESMO Congress Madrid, Spain, 26 - 30 September 2014 NSCLC, EARLY STAGE Oral : 1176O Citation: Annals of Oncology, Volume 25, Supplement 4, 2014 IMPACT OF HARVESTED LYMPH NODES COUNT ON STAGING AND SURVIVAL AT RADICAL RESECTION FOR NON-SMALL CELL LUNG CANCER: A MINIMUM OF 14 LYMPH NODES SHOULD BE SAMPLED 1 2 3 4 5 6 7 8 1 W. Liang , H. Pan , Q. Wang , L. Liu , G. Jiang , D. Liu , Z. Wang , Z. Zhu , J. He 1 Department of Thoracic Oncology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 2 Thoracic Oncology, The first affiliated hospital of Guangzhou Medical School, Guangzhou, 3 Department of Thoracic Surgery, Shanghai Zhongshan Hospital of Fudan University, Shanghai, 4 Department of Thoracic Surgery, West Hospital, Sichuan University, Sichuan, 5 Department of Thoracic Surgery, Shanghai Pulmonary Hospital of Tongji University, Shanghai, 6 Department of Thoracic Surgery, and Japan Friendship Hospital, Beijing, 7 Department of Thoracic Surgery, Shenzhen Peoples Hospital, Shenzhen, 8 Department of Thoracic Surgery, Cancer Center of Sun Ya University, Guangzhou, Aim: Lymph node (LN) status is the most important prognostic factor in patients with resectable non-small cell lung cancer (NSCLC) who underwent radical surgery. However, the impact of total number of LNs being harvested during surgery on staging and overall survival (OS) remains controversial. In addition, the minimum count of LN that should be examined to accura y determine stage or identify high risk patients has not been mended. Methods: A cohort of 5729 NSCLC patients from a multi-institutional registry